TECHNOLOGY
A microscopic look at chromosomes
A microscopic look at chromosomes
thing that could keep Illumina alive and relevant to the industry : innovation .
Driving innovation to succeed In 2006 , when news of another company being close to creating its first rapid readout of an individual human genome reached Flatley , he knew that was the answer for Illumina : either build or buy a sequencing technology of its own .
Flatley bought the company Solexa , which had been developing the concept of sequencing by synthesis — both a faster and cheaper process than traditional methods — and the acquisition has since proven to be a turning point for the company .
To date , Illumina has spent more than US $ 1.2 billion on acquisitions , but the ability to innovate and improve the technology of the companies it buys is what has kept Illumina at the helm of the genome sequencing industry .
In an interview with Forbes back in April , Flatley noted that the reason for Illumina ’ s vast success was attributed to remaining technical at the top .
“ We think it ’ s very important that the people who lead our company , which you might think of as my top 20 to 50 executives , have technology
10 August 2015